The acute purinergic receptor P2X4 blockade exerts neuroprotective and neuro-rehabilitative effects after ischemic stroke by reducing the numbers of infiltrating pro-inflammatory myeloid cells17. Here, P2RX4 is linked to ischemic stroke.